260 related articles for article (PubMed ID: 28656268)
1. Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.
Yu G; Li C; Xie W; Wang Z; Gao H; Cao L; Hao L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1140-1148. PubMed ID: 28656268
[TBL] [Abstract][Full Text] [Related]
2. Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Sailer V; Charpentier A; Dietrich J; Vogt TJ; Franzen A; Bootz F; Dietrich D; Schroeck A
PLoS One; 2018; 13(2):e0192742. PubMed ID: 29425237
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma.
Guo W; Lv P; Liu S; Xu F; Guo Y; Shen S; Liang J; Kuang G; Dong Z
Mol Carcinog; 2018 Jul; 57(7):854-865. PubMed ID: 29566283
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lncRNA C5orf66-AS1 inhibits osteosarcoma cell proliferation and invasion via miR-149-5p upregulation.
Zhang H; Song J
Oncol Lett; 2021 Nov; 22(5):757. PubMed ID: 34539861
[TBL] [Abstract][Full Text] [Related]
6. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma.
Lu X; Zhou C; Li R; Liang Z; Zhai W; Zhao L; Zhang S
Tumour Biol; 2016 Jul; 37(7):9699-707. PubMed ID: 26803513
[TBL] [Abstract][Full Text] [Related]
7. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma.
Wang S; Wu Z; Wei L; Zhang J
BMC Endocr Disord; 2019 Aug; 19(1):90. PubMed ID: 31455321
[TBL] [Abstract][Full Text] [Related]
9. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis.
Zhou Q; Li H; Jing J; Yuan Y; Sun L
Onco Targets Ther; 2020; 13():2795-2805. PubMed ID: 32308414
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
13. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
14. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
[TBL] [Abstract][Full Text] [Related]
15. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling in human null cell pituitary adenoma tissue.
Hu J; Song H; Wang X; Shen Y; Chen F; Liu Y; Li S; Wang Y; Shou X; Zhang Y; Hu R
Pituitary; 2007; 10(1):47-52. PubMed ID: 17308960
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
Razavi H; Katanforosh A
BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
[TBL] [Abstract][Full Text] [Related]
18. Long-noncoding RNA IFNG-AS1 exerts oncogenic properties by interacting with epithelial splicing regulatory protein 2 (ESRP2) in pituitary adenomas.
Lu G; Duan J; Zhou D
Pathol Res Pract; 2018 Dec; 214(12):2054-2061. PubMed ID: 30322807
[TBL] [Abstract][Full Text] [Related]
19. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.
Zang W; Wang T; Wang Y; Chen X; Du Y; Sun Q; Li M; Dong Z; Zhao G
Oncotarget; 2016 Apr; 7(15):19960-74. PubMed ID: 26799587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
